Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lucinda L Tennant"'
Autor:
Ramses Sadek, Olivier Rixe, David Munn, Christopher M Smith, Yousef Zakharia, Joseph Drabick, Kenneth F Grossmann, Robert R McWilliams, Montaser F Shaheen, Ravindra Kolhe, Rafal Pacholczyk, Lucinda L Tennant, Eugene P Kennedy, Charles J Link Jr, Nicholas N Vahanian, Jiayi Yu, Steven S Shen, Erik L Brincks, Gabriela R Rossi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background The indoleamine 2,3-dioxygenase (IDO) pathway is a key counter-regulatory mechanism that, in cancer, is exploited by tumors to evade antitumor immunity. Indoximod is a small-molecule IDO pathway inhibitor that reverses the immunosuppressiv
Externí odkaz:
https://doaj.org/article/3e3e02066379461ebd661d3bcc62f60a
Autor:
Riker AI; Department of Surgery, Advocate Cancer Institute, Advocate Christ Medical Center, Oak Lawn, IL., Rossi GR; NewLink Genetics, Ames, IA., Masih P; NewLink Genetics, Ames, IA., Alsfeld LC; Department of Internal Medicine, Medical University of South Carolina, Charleston, SC., Denham F; Department of General Surgery, Carilion Clinic, Roanoke, VA., Tennant L; NewLink Genetics, Ames, IA., Ramsey WJ; NewLink Genetics, Ames, IA., Vahanian NN; NewLink Genetics, Ames, IA., Link CJ; NewLink Genetics, Ames, IA.
Publikováno v:
Ochsner journal [Ochsner J] 2014 Summer; Vol. 14 (2), pp. 164-74.
Autor:
Hemstreet GP 3rd; Department of Urology, University of Nebraska Medical Center, Omaha, NE, USA., Rossi GR, Pisarev VM, Enke CA, Helfner L, Hauke RJ, Tennant L, Ramsey WJ, Vahanian NN, Link CJ
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2013 Jan; Vol. 36 (1), pp. 57-65.
Autor:
Burt RK; Northwestern University School of Medicine, Division of Immunotherapy, Chicago, Illinois 60611, USA. rburt@nwu.edu, Drobyski WR, Seregina T, Traynor A, Oyama Y, Keever-Taylor C, Stefka J, Kuzel TM, Brush M, Rodriquez J, Burns W, Tennant L, Link C
Publikováno v:
Experimental hematology [Exp Hematol] 2003 Oct; Vol. 31 (10), pp. 903-10.